| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/05/2005 | US20050096459 Oligomeric receptor ligand pair member complexes |
| 05/05/2005 | US20050096285 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 05/05/2005 | US20050096283 Contraceptives for mammals with nucleic acid |
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050096268 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/05/2005 | US20050096258 Methods and compositions for treating gastrointestinal tract mucin production associated disease conditions |
| 05/05/2005 | US20050096257 Administering platelet derived growth factor antagonist and endothelial growth factor antagonist |
| 05/05/2005 | US20050095682 Campylobacter polypeptides and methods of use |
| 05/05/2005 | US20050095675 Mucin peptide with immunoenhancing properties |
| 05/05/2005 | US20050095667 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins |
| 05/05/2005 | US20050095650 screening for an agent that modulates capsaicin receptor function |
| 05/05/2005 | US20050095618 Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS) |
| 05/05/2005 | US20050095586 Expression vector comprising nucleotide sequences coding homeobox proteins for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 05/05/2005 | US20050095584 Method for determining early HCV seroconversion |
| 05/05/2005 | US20050095298 Three dimensionally crosslinked agarose bead with grass pollen covalently bound; immunotherapy, vaccines, diagnosis |
| 05/05/2005 | US20050095282 Methods and compositions for inducing autoimmunity in the treatment of cancers |
| 05/05/2005 | US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells |
| 05/05/2005 | US20050095256 Nucleotide sequence encoding merozoite surface protein-1 of plasmodium strain with reduced adenine and thymine; vectors, organisms, host cells |
| 05/05/2005 | US20050095255 For primates; p42 nucleic acid encoding a p42 polypeptide from the C-terminal processing fragment of Plasmodium falciparum major merozoite surface protein gp195 which hybridizes under high stringency conditions |
| 05/05/2005 | US20050095254 DNA immunization against Chlamydia infection |
| 05/05/2005 | US20050095253 inducing cancer immune response |
| 05/05/2005 | US20050095250 treating breast concer by administering a monoclonal antibody with an oligo- beta -(1,3)-glucan and a carrier |
| 05/05/2005 | US20050095249 Protein markers for lung cancer and use thereof |
| 05/05/2005 | US20050095246 Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators |
| 05/05/2005 | US20050095245 Topical time release dosage form; vaginal conditions |
| 05/05/2005 | US20050095244 Monoclonal antibodies or antigen binding portions; anticancer agents |
| 05/05/2005 | US20050095243 Contacting the mixed population of cells with a BLyS(B lymphocte stimulator) antagonist and a CD20 antigen binding antibody; immunoadhesin; B cell neoplasm or a B-cell regulated autoimmune disorder |
| 05/05/2005 | US20050095241 Estrogen receptor modulators and uses thereof |
| 05/05/2005 | US20050095240 NaCT as a target for lifespan expansion and weight reduction |
| 05/05/2005 | US20050095239 Methods and compositions for treating Alzheimer's disease |
| 05/05/2005 | US20050095238 Treating a disease associated with leukocyte infiltration of mucosal tissues, such as inflammatory bowel disease, asthma, graft vs host disease, pancreatitis, diabetes, or sinutitis with a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin |
| 05/05/2005 | US20050095236 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 05/05/2005 | US20050095230 For treatment of cancer or virus infection (HIV) |
| 05/05/2005 | US20050095201 Protein or peptide containing asparagyl-4-aminobutane and/or glutamyl-4-aminobutane residues; diagnostic magnetic resonance imaging |
| 05/04/2005 | EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/04/2005 | EP1528101A1 Immortalized avian cell lines for virus production |
| 05/04/2005 | EP1527771A2 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols |
| 05/04/2005 | EP1527343A2 Organic compounds |
| 05/04/2005 | EP1527178A2 Novel class ii cytokine receptors and uses thereof |
| 05/04/2005 | EP1527177A2 Muc-1 antigen with reduced number of vntr repeat units |
| 05/04/2005 | EP1527159A1 Probiotic propionibacterium jensenii 702 |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1527089A2 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 05/04/2005 | EP1527085A2 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 05/04/2005 | EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer |
| 05/04/2005 | EP1527080A2 Campylobacter glycans and glycopeptides |
| 05/04/2005 | EP1526868A2 Antibodies |
| 05/04/2005 | EP1526863A2 Using heat shock proteins to increase immune response |
| 05/04/2005 | EP1315520B1 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites |
| 05/04/2005 | EP0835266B1 Modified/chimeric superantigens and their use |
| 05/04/2005 | EP0781340B1 Vaccine against group A Streptococcal infection |
| 05/04/2005 | EP0668916B1 Haemophilus outer membrane protein |
| 05/04/2005 | CN1612935A Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 05/04/2005 | CN1612934A Human monoclonal antibodies to dendritic cells |
| 05/04/2005 | CN1612753A Mycobacterial vaccine |
| 05/04/2005 | CN1612751A Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound |
| 05/04/2005 | CN1612750A TACI-immunoglobulin fusion proteins |
| 05/04/2005 | CN1612749A Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
| 05/04/2005 | CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 05/04/2005 | CN1612689A Stable liquid pharmaceutical formulation of IgG antibodies |
| 05/04/2005 | CN1611512A Poly peptide for therapeutic antitumour vaccive |
| 05/04/2005 | CN1611264A CCA gene vaccine, and its establishing method and use for preparing vaccine for preventing and treating tumour |
| 05/04/2005 | CN1611263A Foot-mouth disease vaccine tag |
| 05/04/2005 | CN1200106C Dual-plasmid gene vaccine resisting against hepatitis B virus, and its preparing process and application |
| 05/04/2005 | CN1200103C Fowl castration recombinant gene vector |
| 05/04/2005 | CN1200101C Universal farm animal castration vaccine gene and recombinant gene vector |
| 05/04/2005 | CN1200002C Human melanin tumour monoclonal antibody, and its preparing method and use |
| 05/04/2005 | CN1199692C Polysaccharide with certain immunological activity and its preparation |
| 05/04/2005 | CN1199691C Process for preparing acellular short corynebacteria prepaation |
| 05/04/2005 | CN1199639C Medicine for curing subacute tyroiditis |
| 05/04/2005 | CN1199567C Hybrid matrix implants and explants |
| 05/03/2005 | US6887989 Sequences from Piscirickettsia salmonis |
| 05/03/2005 | US6887977 Methods and materials relating to CD8-tropic HIV-1 |
| 05/03/2005 | US6887975 Serpentine protein for use in the treatment of cancer |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | US6887843 Chlamydia protein, gene sequence and uses thereof |
| 05/03/2005 | US6887707 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA |
| 05/03/2005 | US6887699 Recombinant negative strand RNA virus expression systems and vaccines |
| 05/03/2005 | US6887686 Cloning and expression of Haemophilus somnus transferrin-binding proteins |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887673 Containing light chain and a heavy chain peptide; anticarcinogenic agent |
| 05/03/2005 | US6887663 Vaccines for diagnosis/prevention/attenuation of infection; genetic engineering |
| 05/03/2005 | US6887484 Vaccine composition containing a promoter peptide |
| 05/03/2005 | US6887483 Non-toxic mutants of pathogenic gram-negative bacteria |
| 05/03/2005 | US6887482 Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins |
| 05/03/2005 | US6887481 Bacterial-derived molecules and therapeutic and diagnostic uses therefor |
| 05/03/2005 | US6887480 For prophylaxis and therapy of pneumococcal infection, especially by Streptococcus pneumoniae |
| 05/03/2005 | US6887479 Attenuated recombinant rabies virus mutants and live vaccines thereof |
| 05/03/2005 | US6887478 Genetic engineered caspid genes and proteins which which mimic epitopes on human and animal DNA viruses, used for prophylaxis of viral diseases; immunology |
| 05/03/2005 | US6887476 Method for treating pain with botulinum toxin type B |
| 05/03/2005 | US6887474 Compositions and methods for producing vascular occlusion |
| 05/03/2005 | US6887473 Administering as antitumor, antimetastasis, antiinflammatory, or anticarcinogenic agent |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887470 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability |
| 05/03/2005 | US6887469 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 05/03/2005 | US6887468 Antibody kits for selectively inhibiting VEGF |
| 05/03/2005 | US6887466 Activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand; HIV immunotherapy; T cells can be genetically transduced and used for immunotherapy |
| 05/03/2005 | US6887464 Plurality of genetically engineered nucleocapsid protein monomers derived from duck hepatitis B virus; immune response, gene therapy |
| 05/03/2005 | CA2366316C Multi-component vaccine comprising at least three antigens to protect against disease caused by haemophilus influenzae |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |